Dr. Timothy Palzkill, professor of Pharmacology and Chemical Biology and Molecular Virology and Microbiology, and his research team have been studying mechanisms of resistance to the beta-lactam ...

Relebactam has been designed to inhibit a key resistance mechanism that limits the effectiveness of beta lactam antibiotics, including carbapenems like imipenem that have become last-line ...